Inspire Medical Systems (Inspire Medical Systems) 14-Day RSI : 56.13 (As of Apr. 26, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Inspire Medical Systems 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-04-26), Inspire Medical Systems's 14-Day RSI is 56.13.

The industry rank for Inspire Medical Systems's 14-Day RSI or its related term are showing as below:

INSP's 14-Day RSI is ranked worse than
83.26% of 884 companies
in the Medical Devices & Instruments industry
Industry Median: 45.105 vs INSP: 56.13

Competitive Comparison of Inspire Medical Systems's 14-Day RSI

For the Medical Devices subindustry, Inspire Medical Systems's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inspire Medical Systems's 14-Day RSI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Inspire Medical Systems's 14-Day RSI falls into.

Inspire Medical Systems (NYSE:INSP) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI

100

–

[ 100

( 1 + Average Gain

Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inspire Medical Systems (NYSE:INSP) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.

Inspire Medical Systems 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Inspire Medical Systems's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.

Inspire Medical Systems (Inspire Medical Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (NYSE:INSP) » Definitions » 14-Day RSI

Comparable Companies

Traded in Other Exchanges

2DR:Germany 2DR:Germany

Address

5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416

Website

https://www.inspiresleep.com

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Executives

Timothy P. Herbert	director, 10 percent owner, officer: CEO and President	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Jerry C Griffin	director	887L INDUSTRIAL ROAD, SAN CARLOS CA 94070
Carlton Weatherby	officer: Chief Strategy Officer	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Steven Jandrich	officer: Chief Comp Off & VP, Human Res	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Philip Ebeling	officer: Chief Operating Officer	INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY MN 55416
John Rondoni	officer: Chief Technology Officer	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Richard Buchholz	officer: Chief Financial Officer	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Randy Ban	officer: Senior VP. & Sales & Marketing	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Marilyn C Nelson	director	C/O EXXON MOBIL CORP, 5959 LAS COLINAS BLVD., IRVING TX 75039-2298
Cynthia Burks	director	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Charisse Y Sparks	director	C/O INSPIRE MEDICAL SYSTEMS, INC., 9700 63RD AVENUE NORTH, SUITE 200, MAPLE GROVE MN 55369
Georgia Melenikiotou	director	C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BOULEVARD, SUITE 1600, GOLDEN VALLEY MN 55416
Bryan K Phillips	officer: See Remarks	9924 WEST 74TH STREET, EDEN PRAIRIE MN 55344
Shelley G. Broader	director	880 CARILLON PARKWAY, ST. PETERSBURG FL 33702
Casey M Tansey	director, 10 percent owner	2735 SAND HILL ROAD, MENLO PARK CA 94025